Juan‐Carlos Gómez

Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison

David H. Adams, Lu Zhang, Brian A. Millen et al. · Schizophrenia Research and Treatment · 2014 · 76 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Doses of olanzapine, risperidone, and haloperidol used in clinical practice: Results of a prospective pharmacoepidemiologic study

José Antonio Sacristán, Juan‐Carlos Gómez, Ángel L. Montejo et al. · Clinical Therapeutics · 2000 · 54 citations

Pharmacy, Pharmacotherapy, Psychiatry +13

Clinical development of pomaglumetad methionil: A non-dopaminergic treatment for schizophrenia

Bruce J. Kinon, Juan‐Carlos Gómez · Neuropharmacology · 2012 · 48 citations

Medicine, Pharmacology, Psychiatry +12

Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients

Julio Bobes, J. Gibert, Antonio Ciudad et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2003 · 40 citations

Medicine, Pharmacotherapy, Psychiatry +16

A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation

Hideaki Katagiri, Shinji Fujikoshi, Takuya Suzuki et al. · BMC Psychiatry · 2013 · 26 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17